Key Financial Data Of Reporting Company

TORII PHARMACEUTICAL CO., LTD. - Filing #7314142

Concept As at
2024-06-30
2024-01-01 to
2024-06-30
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-06-30
2023-01-01 to
2023-06-30
Key financial data of reporting company
Business results of reporting company
Net sales
28,309,000,000 JPY
54,638,000,000 JPY
25,699,000,000 JPY
Ordinary profit (loss)
2,985,000,000 JPY
5,307,000,000 JPY
1,543,000,000 JPY
Profit (loss)
2,221,000,000 JPY
4,119,000,000 JPY
1,086,000,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
Share capital
5,190,000,000 JPY
5,190,000,000 JPY
5,190,000,000 JPY
Total number of issued shares
28,800,000 xbrli:shares
28,800,000 xbrli:shares
28,800,000 xbrli:shares
Net assets
120,443,000,000 JPY
120,134,000,000 JPY
118,666,000,000 JPY
Total assets
134,344,000,000 JPY
133,432,000,000 JPY
131,670,000,000 JPY
Dividend paid per share
60.00
120.00
50.00
Basic earnings (loss) per share
79.04
146.60
38.68
Diluted earnings per share
Equity-to-asset ratio
0.897 xbrli:pure
0.900 xbrli:pure
0.901 xbrli:pure
Net cash provided by (used in) operating activities
2,918,000,000 JPY
-3,123,000,000 JPY
-1,461,000,000 JPY
Net cash provided by (used in) investing activities
-2,512,000,000 JPY
-3,779,000,000 JPY
-5,180,000,000 JPY
Net cash provided by (used in) financing activities
-2,152,000,000 JPY
-3,835,000,000 JPY
-2,287,000,000 JPY
Cash and cash equivalents
32,934,000,000 JPY
34,681,000,000 JPY
36,490,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.